BioAdvanced

BioAdvanced Market Overview

BioAdvanced, owned by family-operated SBM Company, demonstrates significant in-store retail concentration across major home improvement channels during the January–August 2026 period, according to Grips Intelligence. Amazon dominates the revenue share at 42.1%, followed by Lowe's at 28.1% and Menards at 15.6%, with the brand maintaining an average product price of $19.54 across channels. Despite a modest 3.4% increase in average price since the start of the year, BioAdvanced faced notable headwinds with revenue declining 22.9% over the data period, reflecting challenging market conditions. Price positioning varies considerably across retailers, with Menards offerings averaging $15–$24 compared to Home Depot's premium range of $29–$88, suggesting distinct pricing strategies by channel. The portfolio spans multiple product formats including granules, concentrates, and ready-to-use sprays, with top SKUs across all channels averaging between $20–$27 at standard price points.